“We are entering a new era in cancer management,” said Dr. Ravasco. Considering the clinical evidence now available, adjuvant nutritional intervention is an essential addition to the multidisciplinary care of patients with cancer, she added.
She and her associates are planning a larger, four-arm trial to look at the combined effects of nutritional counseling and supplements vs. counseling alone, supplements alone, and no intervention. This will initially involve patients with high-risk cancers, including colorectal, gastric, esophageal, and head and neck cancers, but could eventually be expanded to include patients with any solid tumor.
Disclosures: The NUTRIDIS study was supported by a grant from PRASFARMA SA in Barcelona. The randomized trial received a grant from N?cleo Regional do Sul da Liga Portuguesa contra o Cancro–Terry Fox Foundation. Dr. Biete and Dr. Ravasco reported no conflicts of interest.